Early Pregnancy Use of Anti-CGRP Monoclonal Antibodies and Propranolol and Spontaneous Abortion Risk

Leah K. Flatman, Lisiane F. Leal, Elizabeth Leroux, Richard B. Lipton, Anick Bérard

Open source

DOI
10.1001/jamaneurol.2026.3573
Published
2026-10-12
Container
JAMA Neurology
Publisher
American Medical Association (AMA)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1001/jamaneurol.2026.3573,
  title = {Early Pregnancy Use of Anti-CGRP Monoclonal Antibodies and Propranolol and Spontaneous Abortion Risk},
  author = {Leah K. Flatman and Lisiane F. Leal and Elizabeth Leroux and Richard B. Lipton and Anick Bérard},
  year = {2026},
  journal = {JAMA Neurology},
  doi = {10.1001/jamaneurol.2026.3573},
  url = {https://doi.org/10.1001/jamaneurol.2026.3573}
}

RIS

TY  - JOUR
TI  - Early Pregnancy Use of Anti-CGRP Monoclonal Antibodies and Propranolol and Spontaneous Abortion Risk
AU  - Leah K. Flatman
AU  - Lisiane F. Leal
AU  - Elizabeth Leroux
AU  - Richard B. Lipton
AU  - Anick Bérard
PY  - 2026
JO  - JAMA Neurology
DO  - 10.1001/jamaneurol.2026.3573
UR  - https://doi.org/10.1001/jamaneurol.2026.3573
ER  - 

APA

Flatman, L. K., Leal, L. F., Leroux, E., Lipton, R. B., & Bérard, A. (2026). Early Pregnancy Use of Anti-CGRP Monoclonal Antibodies and Propranolol and Spontaneous Abortion Risk. JAMA Neurology. https://doi.org/10.1001/jamaneurol.2026.3573

Source records